Pre-term Birth
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
HologicMARLBOROUGH, MA
1 programfFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm BirthN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciences17P
HologicfFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth
Clinical Trials (2)
Total enrollment: 2,010 patients across 2 trials
Improving Pregnancy Outcomes With Progesterone
Start: Feb 2018Est. completion: Aug 2020800 patients
Phase 3Completed
fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth
Start: Oct 2013Est. completion: Sep 20161,210 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.